These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8697721)

  • 1. Use of continuous haemofiltration to assess the rate of lactate metabolism in acute renal failure.
    Wright DA; Forni LG; Carr P; Treacher DF; Hilton PJ
    Clin Sci (Lond); 1996 Jun; 90(6):507-10. PubMed ID: 8697721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlactataemia and metabolic acidosis during haemofiltration using lactate-buffered fluids.
    Davenport A; Will EJ; Davison AM
    Nephron; 1991; 59(3):461-5. PubMed ID: 1758538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction.
    McLean AG; Davenport A; Cox D; Sweny P
    Kidney Int; 2000 Oct; 58(4):1765-72. PubMed ID: 11012911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypochloraemic alkalosis after high-flux continuous haemofiltration and continuous arteriovenous haemofiltration with dialysis.
    Davenport A; Worth DP; Will EJ
    Lancet; 1988 Mar; 1(8586):658. PubMed ID: 2894600
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of ranitidine in patients undergoing haemofiltration.
    Gladziwa U; Krishna DR; Klotz U; Ittel TH; Schunkert H; Glöckner WM; Mann H
    Eur J Clin Pharmacol; 1988; 35(4):427-30. PubMed ID: 3197752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of blood lactate measurements in ICU: an evaluation of the role in the management of patients on haemofiltration.
    Holloway P; Benham S; St John A
    Clin Chim Acta; 2001 May; 307(1-2):9-13. PubMed ID: 11369330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous venovenous hemofiltration in acute renal failure: is a bicarbonate- or lactate-buffered substitution better?
    Kierdorf H; Leue C; Heintz B; Riehl J; Melzer H; Sieberth HG
    Contrib Nephrol; 1995; 116():38-47. PubMed ID: 8529380
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients.
    Barenbrock M; Hausberg M; Matzkies F; de la Motte S; Schaefer RM
    Kidney Int; 2000 Oct; 58(4):1751-7. PubMed ID: 11012909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of atracurium and laudanosine in the urine and by continuous venovenous haemofiltration.
    Shearer ES; O'Sullivan EP; Hunter JM
    Br J Anaesth; 1991 Nov; 67(5):569-73. PubMed ID: 1751271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis.
    Hilton PJ; Taylor J; Forni LG; Treacher DF
    QJM; 1998 Apr; 91(4):279-83. PubMed ID: 9666950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous venovenous haemofiltration using a citrate buffered substitution fluid.
    Schmitz M; Taskaya G; Plum J; Hennersdorf M; Sucker C; Grabensee B; Hetzel GR
    Anaesth Intensive Care; 2007 Aug; 35(4):529-35. PubMed ID: 18020071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of lactate-buffered solutions on the acid-base status of patients with renal failure.
    Davenport A; Will EJ; Davison AM
    Nephrol Dial Transplant; 1989; 4(9):800-4. PubMed ID: 2516612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrolyte mass balance during CVVH: lactate vs. bicarbonate-buffered replacement fluids.
    Tan HK; Uchino S; Bellomo R
    Ren Fail; 2004 Mar; 26(2):149-53. PubMed ID: 15287198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of continuous arteriovenous haemofiltration on pharmacokinetics of amrinone.
    Lawless S; Restaino I; Azin S; Corddry D
    Clin Pharmacokinet; 1993 Jul; 25(1):80-2. PubMed ID: 8354019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of lactate-buffered high-volume hemofiltration on acid-base balance.
    Cole L; Bellomo R; Baldwin I; Hayhoe M; Ronco C
    Intensive Care Med; 2003 Jul; 29(7):1113-20. PubMed ID: 12783161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular outcome in critically ill patients treated with continuous haemofiltration--beneficial effects of bicarbonate-buffered replacement fluids.
    Barenbrock M; Schaefer RM
    EDTNA ERCA J; 2002; Suppl 2():4-6. PubMed ID: 12371722
    [No Abstract]   [Full Text] [Related]  

  • 17. [Continuous hemofiltration in the treatment of acute kidney failure in multiple organ failure].
    Robert R; Rouffineau J; Descoins P; Malin F; Antoun S; Carretier M
    Presse Med; 1990 Oct; 19(35):1615-8. PubMed ID: 2147253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters.
    Troyanov S; Cardinal J; Geadah D; Parent D; Courteau S; Caron S; Leblanc M
    Nephrol Dial Transplant; 2003 May; 18(5):961-6. PubMed ID: 12686672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is continuous haemofiltration superior to intermittent dialysis and haemofiltration treatment?
    Sieberth HG; Kierdorf H
    Adv Exp Med Biol; 1989; 260():181-92. PubMed ID: 2696367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefotaxime and desacetylcefotaxime in renal failure patients undergoing continuous arteriovenous haemofiltration.
    Hasegawa H; Takahashi K; Imada A; Horiuchi A
    Drugs; 1988; 35 Suppl 2():78-81. PubMed ID: 3396493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.